XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   126,474,000      
Beginning balance at Dec. 31, 2022 $ 1,116,589 $ 126 $ 1,244,504 $ (57,488) $ (70,553)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (7,600,000)      
Repurchases of common stock (151,311) $ (7) (151,304)    
Issuance of common stock upon exercise of stock options (in shares)   18,000      
Issuance of common stock upon exercise of stock options 144   144    
Net share settlement of equity awards (in shares)   736,000      
Net share settlement of equity awards (7,735) $ 1 (7,736)    
Share-based compensation expense 34,736   34,736    
Other comprehensive (loss) income 12,150     12,150  
Net (loss) income 2,186       2,186
Ending balance (in shares) at Mar. 31, 2023   119,628,000      
Ending balance at Mar. 31, 2023 1,006,759 $ 120 1,120,344 (45,338) (68,367)
Beginning balance (in shares) at Dec. 31, 2022   126,474,000      
Beginning balance at Dec. 31, 2022 $ 1,116,589 $ 126 1,244,504 (57,488) (70,553)
Ending balance (in shares) at Dec. 31, 2023 102,823,700 102,824,000      
Ending balance at Dec. 31, 2023 $ 944,618 $ 103 1,031,627 (34,739) (52,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (2,116,000)      
Repurchases of common stock (114) $ (2) (112)    
Net share settlement of equity awards (in shares)   862,000      
Net share settlement of equity awards (4,293) $ 1 (4,294)    
Share-based compensation expense 30,616   30,616    
Other comprehensive (loss) income (5,933)     (5,933)  
Net (loss) income $ (1,420)       (1,420)
Ending balance (in shares) at Mar. 31, 2024 101,569,933 101,570,000      
Ending balance at Mar. 31, 2024 $ 963,474 $ 102 $ 1,057,837 $ (40,672) $ (53,793)